FUT4 and head and neck squamous cell carcinoma: First, we compared the frequency of granulocytic MDSC (LIN−CD11b+CD15+) in the circulation of healthy donors and HNSCC patients prior to cetuximab treatment (gating strategies shown in Additional file 1: Figure S1A).